RT Journal Article
SR Electronic
T1 Spontaneous cerebrovascular reactivity at rest in older adults with and without mild cognitive impairment and memory deficits
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.06.18.24309109
DO 10.1101/2024.06.18.24309109
A1 Engstrom, Allison C
A1 Alitin, John Paul
A1 Kapoor, Arunima
A1 Dutt, Shubir
A1 Lohman, Trevor
A1 Sible, Isabel J
A1 Marshall, Anisa J
A1 Shenasa, Fatemah
A1 Gaubert, Aimée
A1 Ferrer, Farrah
A1 Nguyen, Amy
A1 Bradford, David Robert
A1 Rodgers, Kathleen
A1 Sordo, Lorena
A1 Head, Elizabeth
A1 Shao, Xingfeng
A1 Wang, Danny JJ
A1 Nation, Daniel A
YR 2024
UL http://medrxiv.org/content/early/2024/06/19/2024.06.18.24309109.abstract
AB Background Older adults with mild cognitive impairment (MCI) exhibit deficits in cerebrovascular reactivity (CVR), suggesting CVR is a biomarker for vascular contributions to MCI. This study examined if spontaneous CVR is associated with MCI and memory impairment.Methods 161 older adults free of dementia or major neurological/psychiatric disorders were recruited. Participants underwent clinical interviews, cognitive testing, venipuncture for Alzheimer’s biomarkers, and brain MRI. Spontaneous CVR was quantified during 5 minutes of rest.Results Whole brain CVR was negatively associated with age, but not MCI. Lower CVR in the parahippocampal gyrus (PHG) was found in participants with MCI and was linked to worse memory performance on memory tests. Results remained significant after adjusting for Alzheimer’s biomarkers and vascular risk factors.Conclusion Spontaneous CVR deficits in the PHG are observed in older adults with MCI and memory impairment, indicating medial temporal microvascular dysfunction’s role in cognitive decline.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by National Institutes of Health grants (DAN: R01AG064228, R01AG060049, R01AG082073, P01AG052350, P30AG066530), (EH: UCI ADRC P30AG066519) and the Canadian Institutes of Health Research (AK: DFD-170763).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The VaSC Study was approved by the University of Southern California (HS-14-00784) and University of California Irvine (HS-2019-5324) Institutional Review Boards, and all participants gave informed consent prior to participating in the study.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authorsBBBblood-brain barrierCBFcerebral blood flowCVRcerebrovascular reactivityETCO2end-tidal carbon dioxideLM2Logical Memory 2MCImild cognitive impairmentMTLmedial temporal lobePHGparahippocampal gyruspCASLpseudo-continuous arterial spin labelingRAVLTRey Auditory Verbal Learning TestVRFsvascular risk factors